| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.600 | None | 0.885 | 26 | 0 | 1993 | 2019 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.600 | None | 1.000 | 11 | 0 | 2012 | 2020 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
disease | 0.560 | None | 1.000 | 7 | 0 | 2012 | 2018 | ||||||||
|
ring finger protein 43 | 0.584 | 0.577 | 0.73 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 1.000 | 29 | 0 | 2002 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 1.000 | 23 | 0 | 2000 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 1.000 | 22 | 1 | 2002 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.400 | None | 1.000 | 18 | 1 | 1995 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.400 | None | 1.000 | 16 | 0 | 1989 | 2019 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.400 | None | 1.000 | 12 | 0 | 2013 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.390 | None | 1.000 | 9 | 2 | 2003 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.360 | None | 1.000 | 7 | 0 | 2006 | 2018 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
disease | 0.350 | None | 1.000 | 7 | 0 | 2013 | 2019 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.320 | None | 0.667 | 3 | 1 | 2006 | 2018 | ||||||||
|
protein kinase cAMP-activated catalytic subunit beta | 0.670 | 0.577 | 0.35 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2015 | 2018 | ||||||||
|
mesothelin | 0.525 | 0.692 | 5.9E-25 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2003 | 2017 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2001 | 2006 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2013 | 2019 | ||||||||
|
GNAS complex locus | 0.420 | 0.885 | 0.68 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2007 | 2012 | ||||||||
|
polybromo 1 | 0.566 | 0.615 | 1.00 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2013 | 2017 | ||||||||
|
solute carrier family 5 member 5 | 0.499 | 0.769 | 2.9E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
protein tyrosine phosphatase non-receptor type 3 | 0.647 | 0.462 | 6.7E-09 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
protein kinase cAMP-activated catalytic subunit alpha | 0.606 | 0.692 | 0.97 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
lysine methyltransferase 2C | 0.558 | 0.692 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
paternally expressed 3 | 0.610 | 0.654 | 2.6E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 |